Previous outsourcing reviews had been inconclusive.
We found that there were pressing reasons to keep the function in-house.
Not only did CS provide an excellent service in producing key documents such as submissions for approval to bring new drugs to market, but some £3 million a year could be saved by better sourcing of work that was being done by a variety of different external suppliers.
However, the savings required improvements in organization, processes and equipment.
The improvements were agreed by the client and are being implemented.